5th ICHNO Programme Book

POSTERS

| PROGRAMME & EXHIBITION GUIDE

Early percutaneous endoscopic gastrostomy and nutritional supplementation in

head and neck cancer: An Italian survey

M. Trignani (Italy), A. Di Pilla, M. Taraborrelli, G. Campitelli, G. Santarelli,

M. De Nicola, A. Croce, D. Genovesi

PO-126

Prevention and treatment of oral mucositis in patients treated with chemoradiothe-

rapy with head and neck cancer

A. Mota, E. Netto (Portugal), A. Santos, M. Ferreira, I. Sargento, D. Costa, E. Gouveia,

L. Martins, S. Esteves, M. Roldão

PO-127

How does radiotherapy impact on swallowing in head and neck cancer? Short-term

results of a prospective study

S. Ursino (Italy), V. Seccia, P. Cocuzza, P. Ferrazza, T. Briganti, P. Giusti, M. Grosso,

M. Morganti,

Fattori

PO-128

Late xerostomia in VMAT for oropharyngeal cancer: dosimetric analysis of parotids

outside the PTV

S. Schipani, M. Thomson (United Kingdom), R. Ferguson, D. Grose, A. James, C. Lamb,

C. Pater

son,

S. Smith, M. Rizwanullah

PO-129

Disseminating best practice in oral care

M. Thomson (United Kingdom), B. Quinn, J. Horn, F. Campbell, A. Beasley, S. Hoy,

D. Houghton

PO-130

Prevention of mucositis: episil

in a clinical setting for oral cancer patients under-

going definitive RT

K. Söderström (Sweden), H. Harnesk-Nygren

PO-131

Management of anemia in (chemo)radiotherapy for head and neck cancer:

policies in EORTC centers

S. Nuyts (Belgium)

PO-132

The effect of normal tissue doses on quality of life in nasopharyngeal carcinomas

treated with 3D-CRT

M. Akin (Turkey), L.Z. Arican, B. Aydin, C. Umay, A. Cinkaya, F. Akman

PO-133

Dose related efficacy of LMS-611 in radiotherapy induced xerostomia –

an ex vivo study

C. Paterson (United Kingdom), M. Thomson, B. Caldwell, S. Porteous, A. McLean,

G. Park, C.M. Messow

PO-134